169 related articles for article (PubMed ID: 33735904)
1. The Time Series Behavior of Neutrophil-to-Lymphocyte Ratio in Thyroid Cancer Patients on Tyrosine Kinase Inhibitor Therapy.
Tomoda C; Sugino K; Kitagawa W; Nagahama M; Ito K
ORL J Otorhinolaryngol Relat Spec; 2021; 83(5):347-353. PubMed ID: 33735904
[TBL] [Abstract][Full Text] [Related]
2. Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice.
Ishihara S; Onoda N; Noda S; Tauchi Y; Morisaki T; Asano Y; Kashiwagi S; Takashima T; Ohira M
Endocr J; 2021 Jan; 68(1):63-68. PubMed ID: 32863283
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib.
Fukuda N; Toda K; Fujiwara YU; Wang X; Ohmoto A; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Mitani H; Takahashi S
In Vivo; 2020; 34(5):2859-2864. PubMed ID: 32871825
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma.
Yamazaki H; Sugino K; Matsuzu K; Masaki C; Akaishi J; Hames K; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Masuda M; Ito K
Endocrine; 2020 Oct; 70(1):115-122. PubMed ID: 32307657
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratio.
Xu B; Zhang L; Setoodeh R; Mohanty AS; Landa I; Balzer B; Tiedje V; Ganly I; Dogan S; Fagin JA; Ghossein R
Endocrine; 2022 Jun; 76(3):612-619. PubMed ID: 35149932
[TBL] [Abstract][Full Text] [Related]
6. Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
Park J; Jung HA; Shim JH; Park WY; Kim TH; Lee SH; Kim SW; Ahn MJ; Park K; Chung JH
Eur J Endocrinol; 2021 May; 184(6):837-845. PubMed ID: 33852431
[TBL] [Abstract][Full Text] [Related]
7. Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors.
Chen YM; Lai CH; Rau KM; Huang CH; Chang HC; Chao TY; Tseng CC; Fang WF; Chung YH; Wang YH; Su MC; Huang KT; Liu SF; Chen HC; Chang YC; Chang YP; Wang CC; Lin MC
BMC Cancer; 2016 Nov; 16(1):868. PubMed ID: 27821111
[TBL] [Abstract][Full Text] [Related]
8. Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib.
Fukuda N; Wang X; Ohmoto A; Urasaki T; Sato Y; Nakano K; Nishizawa M; Yunokawa M; Ono M; Tomomatsu J; Takahashi S
In Vivo; 2020; 34(2):709-714. PubMed ID: 32111774
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Differentiated Thyroid Carcinoma Having Distant Metastasis: A Comparison With Thyroglobulin-doubling Rate and Tumor Volume-doubling Rate.
Ito Y; Onoda N; Kihara M; Miya A; Miyauchi A
In Vivo; 2021; 35(2):1125-1132. PubMed ID: 33622910
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer.
Oba T; Maeno K; Amitani M; Shimizu T; Ohno K; Ono M; Ito T; Kanai T; Uehara T; Ito KI
Endocr J; 2021 Nov; 68(11):1329-1336. PubMed ID: 34219074
[TBL] [Abstract][Full Text] [Related]
12. Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
Ono T; Igawa S; Kurahayashi S; Okuma Y; Sugimoto A; Kusuhara S; Ozawa T; Fukui T; Sasaki J; Mitsufuji H; Yokoba M; Kubota M; Katagiri M; Naoki K
Invest New Drugs; 2020 Jun; 38(3):885-893. PubMed ID: 32157598
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients.
Treistman N; Cavalcante LBCP; Gonzalez F; Fernandes PIW; de Andrade FA; Garcis Alves-Junior PA; Corbo R; Bulzico DA; Vaisman F
Endocrine; 2023 Jul; 81(1):141-148. PubMed ID: 36905576
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil to Lymphocyte Ratio as a Prognostic Factor in European Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors.
Aguiar-Bujanda D; Dueñas-Comino A; Saura-Grau S; Ros-Sanjuan L; Blanco-Sanchez MJ; Hernandez-Sosa M; Mori-De Santiago M; Galvan-Ruiz S; Lorenzo-Barreto JE; Vargas-Prado AM; Bohn-Sarmiento U
Oncol Res Treat; 2018; 41(12):755-761. PubMed ID: 30419558
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
[TBL] [Abstract][Full Text] [Related]
16. Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis.
Liu JF; Ba L; Lv H; Lv D; Du JT; Jing XM; Yang NJ; Wang SX; Li C; Li XX
Sci Rep; 2016 Dec; 6():38551. PubMed ID: 27941815
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
Zhang Y; Jiang C; Li J; Sun J; Qu X
Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma.
Park J; Park J; Shin JH; Oh YL; Jung HA; Chung MK; Choe JH; Ahn YC; Kim SW; Chung JH; Kim TH; Noh JM
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921107
[TBL] [Abstract][Full Text] [Related]
19. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
[TBL] [Abstract][Full Text] [Related]
20. The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer.
Cho JS; Park MH; Ryu YJ; Yoon JH
Ann Surg Treat Res; 2015 Apr; 88(4):187-92. PubMed ID: 25844352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
